Study of SyB C-1101 in Patients With Myelodysplastic Syndrome
Clinical trial NCT03495167 · COMPLETED
Trial details
- NCT number
- NCT03495167
- Sponsor
- SymBio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-06
- Primary completion
- 2019-05-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.